drugset / Trial / NCT00970424

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

NCT00970424

Phase 3 Terminated 252 enrolled Forest Laboratories Phenomix · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM) who are receiving background treatment with pioglitazone.

Timeline

Start
2009-08
Primary completion
2010-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Dutogliptin Small molecule Oral